AIPL1
Aryl-hydrocarbon-interacting protein-like 1
Also known as: AIPL1_HUMAN, LCA4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZN9
- Gene
- AIPL1
- Ensembl
- ENSG00000129221
- Chromosome
- 17
- Canonical length
- 384 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
Leber congenital amaurosis (LCA) is the most severe inherited retinopathy with the earliest age of onset and accounts for at least 5% of all inherited retinal diseases. Affected individuals are diagnosed at birth or in the first few months of life with nystagmus, severely impaired vision or blindness and an abnormal or flat electroretinogram. The photoreceptor/pineal-expressed gene, AIPL1, encoding aryl-hydrocarbon interacting protein-like 1, is located within the LCA4 candidate region. The encoded protein contains three tetratricopeptide motifs, consistent with chaperone or nuclear transport activity. Mutations in this gene may cause approximately 20% of recessive LCA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
384 residues, UniProt reviewed canonical sequence.
>Q9NZN9|AIPL1
1 MDAALLLNVE GVKKTILHGG TGELPNFITG SRVIFHFRTM KCDEERTVID DSRQVGQPMH
61 IIIGNMFKLE VWEILLTSMR VHEVAEFWCD TIHTGVYPIL SRSLRQMAQG KDPTEWHVHT
121 CGLANMFAYH TLGYEDLDEL QKEPQPLVFV IELLQVDAPS DYQRETWNLS NHEKMKAVPV
181 LHGEGNRLFK LGRYEEASSK YQEAIICLRN LQTKEKPWEV QWLKLEKMIN TLILNYCQCL
241 LKKEEYYEVL EHTSDILRHH PGIVKAYYVR ARAHAEVWNE AEAKADLQKV LELEPSMQKA
301 VRRELRLLEN RMAEKQEEER LRCRNMLSQG ATQPPAEPPT EPPAQSSTEP PAEPPTAPSA
361 ELSAGPPAEP ATEPPPSPGH SLQHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AIPL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 775 nTPM
Expression across tissuesHPA
Tissue
- retina: 775 nTPM
- choroid plexus: 3.6 nTPM
- bone marrow: 0.6 nTPM
- testis: 0.6 nTPM
- salivary gland: 0.4 nTPM
- skin: 0.4 nTPM
Single-cell type
- rod photoreceptor cells: 2,244 nCPM
- cone photoreceptor cells: 516 nCPM
- müller glia: 51 nCPM
- retinal ganglion cells: 43 nCPM
- retinal bipolar cells: 35 nCPM
- retinal horizontal cells: 24 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
- classical monocyte: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
Brain region
- hypothalamus: 3.1 nTPM
- choroid plexus: 2.9 nTPM
- white matter: 2.8 nTPM
- thalamus: 2.4 nTPM
- pons: 2.3 nTPM
- amygdala: 2.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AIPL1.
Disease | AllUniProt
Conditions AIPL1 is implicated in, by any mechanism.
- Leber congenital amaurosis 4 (LCA4) MIM:604393
Disease | GeneticClinVar
80 pathogenic / likely-pathogenic of 608 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leber congenital amaurosis 4
- AIPL1-related retinopathy
- Leber congenital amaurosis
- Retinal dystrophy
- Retinitis pigmentosa
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- negative regulation of apoptotic process
- phototransduction, visible light
- protein farnesylation
- regulation of opsin-mediated signaling pathway
- retina homeostasis
- visual perception
Molecular functions
- peptidyl-prolyl cis-trans isomerase activity
- unfolded protein binding
- farnesylated protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AIPL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AIPL1 as an antibody target. Whether an autoantibody or antibody against AIPL1 could matter depends on whether native AIPL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AIPL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AIPL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...